Home Brand Post Technology Lleida.net signs a 600,000 euro contract with Colmédica 

Lleida.net signs a 600,000 euro contract with Colmédica 

Lleida.net signs a 600,000 euro contract with Colmédica 


Madrid and Bogota, February 22nd. – Spanish listed Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF) has signed a five-year contract with Colmédica Medicina Prepagada for an estimated total amount of €600,000. 

The technology company, which has been operating in Colombia since 2014, will provide legally valid electronic contracting, notification and signature services for automatic form drafting and signing of patient informed consents and administrative documents. 

Colmédica is a leader in the provision of prepaid healthcare services in Colombia.

The contract signed includes improving and optimizing the administrative management of all the centers in which Colmédica is located. 

The Spanish company has accumulated a total of 309 patents in more than 60 countries for its innovations in the field of certified electronic signature, notification and contracting. 

Its approach to growth is based on a solid development policy in intellectual property and R&D, as well as a reinforcement of its internationalization policy. 

The company, founded in 1995, was first listed on BME Growth in 2015, on the Madrid stock exchange.

It subsequently listed on Euronext Growth Paris in 2018, and on OTC Markets in New York in 2020. Its securities are also traded on the Frankfurt and Stuttgart stock exchanges.


This press release contains statements regarding the future of the company and its innovations. Statements regarding the future may be accompanied by words such as “anticipate”, “believe”, “estimate”, “wait”, “anticipate”, “pretend”, “power”, “plan”, “potential”, the use of future time and other terms of similar meaning. No undue reliance should be placed on these claims. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including uncertainty of the company’s commercial success, ability to protect our intellectual property rights, and other risks. These statements are based on current beliefs and forecasts and refer only to the date of this press release. The company assumes no obligation to publicly update its forward-looking statements, regardless of whether new information, future events or any other circumstance arise.



Please enter your comment!
Please enter your name here